Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma

Takao Hidaka, Takafumi Nakamura, Tomoko Shima, Hiroyuki Yuki, Shigeru Saito*

*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science